X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19537) 19537
Publication (1777) 1777
Book Review (113) 113
Book / eBook (111) 111
Newsletter (26) 26
Conference Proceeding (25) 25
Book Chapter (15) 15
Dissertation (10) 10
Magazine Article (4) 4
Data Set (3) 3
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18393) 18393
female (11494) 11494
index medicus (11286) 11286
oncology (10962) 10962
antineoplastic combined chemotherapy protocols - therapeutic use (10879) 10879
male (10016) 10016
middle aged (8240) 8240
chemotherapy (7164) 7164
adult (6989) 6989
cancer (6983) 6983
aged (6417) 6417
hematology (6027) 6027
treatment outcome (5121) 5121
animals (3504) 3504
prognosis (3089) 3089
care and treatment (3036) 3036
antineoplastic combined chemotherapy protocols - adverse effects (3000) 3000
immunology (2917) 2917
combined modality therapy (2805) 2805
antineoplastic agents - therapeutic use (2800) 2800
antineoplastic combined chemotherapy protocols - administration & dosage (2781) 2781
therapy (2695) 2695
adolescent (2520) 2520
mice (2423) 2423
transplantation (2385) 2385
cell line, tumor (2334) 2334
survival (2250) 2250
research (2177) 2177
disease-free survival (2150) 2150
tumors (2134) 2134
analysis (2099) 2099
aged, 80 and over (2058) 2058
retrospective studies (1999) 1999
health aspects (1952) 1952
apoptosis (1925) 1925
child (1813) 1813
cyclophosphamide - administration & dosage (1770) 1770
antineoplastic agents - pharmacology (1768) 1768
survival analysis (1757) 1757
immunotherapy (1726) 1726
neoplasm staging (1694) 1694
survival rate (1693) 1693
antineoplastic agents (1691) 1691
medicine & public health (1670) 1670
medicine (1661) 1661
drug therapy (1580) 1580
cancer therapies (1548) 1548
remission induction (1512) 1512
expression (1495) 1495
antimitotic agents (1485) 1485
research article (1479) 1479
follow-up studies (1472) 1472
metastasis (1444) 1444
doxorubicin - administration & dosage (1412) 1412
child, preschool (1369) 1369
multidisciplinary sciences (1346) 1346
patients (1321) 1321
leukemia (1314) 1314
science (1310) 1310
breast cancer (1296) 1296
rituximab (1294) 1294
young adult (1288) 1288
lymphomas (1261) 1261
cyclophosphamide (1254) 1254
clinical trials (1242) 1242
apoptosis - drug effects (1238) 1238
risk factors (1202) 1202
recurrence (1176) 1176
article (1172) 1172
antineoplastic combined chemotherapy protocols - pharmacology (1164) 1164
vincristine - administration & dosage (1157) 1157
breast neoplasms - drug therapy (1143) 1143
antibodies, monoclonal - therapeutic use (1132) 1132
toxicity (1093) 1093
antineoplastic agents - administration & dosage (1088) 1088
stem cells (1086) 1086
dose-response relationship, drug (1084) 1084
cisplatin (1052) 1052
time factors (1046) 1046
trial (1046) 1046
pharmacology & pharmacy (1044) 1044
medical research (1040) 1040
drug administration schedule (994) 994
cancer research (985) 985
carcinoma (983) 983
pediatrics (974) 974
children (965) 965
surgery (962) 962
cisplatin - administration & dosage (961) 961
antibodies, monoclonal - administration & dosage (960) 960
hematopoietic stem cell transplantation (959) 959
transplantation, autologous (952) 952
gene expression (944) 944
infant (925) 925
fluorouracil - administration & dosage (920) 920
drug synergism (915) 915
lymphoma (913) 913
non-hodgkins-lymphoma (908) 908
cell proliferation - drug effects (894) 894
neoplasms - drug therapy (893) 893
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (83) 83
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Online Resources - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19072) 19072
Japanese (190) 190
Russian (87) 87
Chinese (80) 80
French (71) 71
German (62) 62
Spanish (32) 32
Polish (31) 31
Italian (18) 18
Hungarian (16) 16
Czech (6) 6
Portuguese (5) 5
Danish (4) 4
Dutch (3) 3
Hebrew (3) 3
Korean (2) 2
Romanian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Finnish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Immunology, Immunotherapy, ISSN 0340-7004, 1/2009, Volume 58, Issue 1, pp. 49 - 59
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 11/2016, Volume 13, Issue 11, pp. 659 - 673
Metronomic chemotherapy describes the close, regular administration of chemotherapy drugs at less-toxic doses over prolonged periods of time. In 2015, the... 
IN-VITRO | ANTIANGIOGENIC ACTIVITY | ONCOLOGY | RANDOMIZED PHASE-II | BREAST-CANCER PATIENTS | ANTITUMOR INNATE IMMUNITY | ORAL TOPOTECAN | CYCLOPHOSPHAMIDE TREATMENT | ANTICANCER DRUGS | CLINICAL PHARMACOKINETICS | DOSE CHEMOTHERAPY | Angiogenesis Inhibitors - immunology | Pyrimidines - immunology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Administration, Metronomic | Breast Neoplasms - immunology | Alkylating Agents - immunology | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Angiogenesis Inhibitors - administration & dosage | Clinical Trials, Phase III as Topic | Colorectal Neoplasms - drug therapy | Tubulin Modulators - administration & dosage | Alkylating Agents - pharmacokinetics | Camptothecin - administration & dosage | Female | Camptothecin - immunology | Camptothecin - pharmacokinetics | Pyrimidines - administration & dosage | Tubulin Modulators - pharmacokinetics | Alkylating Agents - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - immunology | Breast Neoplasms - drug therapy | Forecasting | Randomized Controlled Trials as Topic | Immunity, Cellular - immunology | Colorectal Neoplasms - immunology | Tubulin Modulators - immunology | Pyrimidines - pharmacokinetics | Chemotherapy | Care and treatment | Patient outcomes | Forecasts and trends | Pharmacokinetics | Observations | Methods | Cancer | Index Medicus
Journal Article
Oncotarget, 08/2016, Volume 7, Issue 33, pp. 52810 - 52817
While programmed cell death 1 (PD-1) inhibitors have shown clear anti-tumor efficacy in several solid tumors, prior results in men with metastatic castration... 
Immune response | Immunotherapy | Immunology and Microbiology Section | Enzalutamide | Immunity | PD-1 | Prostate cancer | DOCETAXEL | INFILTRATION | CELL BIOLOGY | CELL LUNG-CANCER | prostate cancer | PEMBROLIZUMAB | MELANOMA | immunotherapy | PD-L1 | NIVOLUMAB | enzalutamide | IPILIMUMAB | ANTIGEN | Phenylthiohydantoin - adverse effects | Hypothyroidism - chemically induced | Humans | Middle Aged | Prostatic Neoplasms, Castration-Resistant - immunology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Myositis - chemically induced | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hypothyroidism - immunology | Myositis - immunology | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Aged, 80 and over | Prostatic Neoplasms, Castration-Resistant - prevention & control | Prostate-Specific Antigen - metabolism | Antibodies, Monoclonal, Humanized - adverse effects | Phenylthiohydantoin - immunology | Drug Administration Schedule | Programmed Cell Death 1 Receptor - metabolism | Antineoplastic Combined Chemotherapy Protocols - immunology | Prostatic Neoplasms, Castration-Resistant - metabolism | Remission Induction | Phenylthiohydantoin - analogs & derivatives | Phenylthiohydantoin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Prostate-Specific Antigen - immunology | Antibodies, Monoclonal, Humanized - immunology | Drug Resistance, Neoplasm - drug effects
Journal Article
Blood, ISSN 0006-4971, 06/2014, Volume 123, Issue 25, pp. 3855 - 3863
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2011, Volume 108, Issue 17, pp. 7142 - 7147
Trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor-2 (HER2/ErbB-2), has become the mainstay of treatment for HER2-positive... 
T lymphocytes | Inoculation | Medical treatment | Antibodies | Cytotoxicity | Breast cancer | Adaptive immunity | Natural killer cells | Tumors | Cancer | Natural killer cell | Innate | Adaptive | Tumor immunology | tumor immunology | TRASTUZUMAB | MECHANISM | MULTIDISCIPLINARY SCIENCES | innate | OVEREXPRESSING HER2 | COMBINATION | HER2-POSITIVE BREAST-CANCER | ADAPTIVE IMMUNITY | adaptive | IMMUNOTHERAPY | MICE | natural killer cell | PHASE-I | ESTABLISHED TUMORS | Receptor, ErbB-2 - genetics | Receptors, Interleukin-1 Type I - immunology | CD8-Positive T-Lymphocytes - transplantation | Humans | Receptors, Interleukin-17 - immunology | Receptors, Interleukin-17 - genetics | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Adoptive Transfer | Interferon Type I - immunology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Antibodies, Monoclonal, Humanized | Receptor, ErbB-2 - immunology | Interferon-gamma - genetics | Antibodies, Monoclonal - immunology | Mammary Neoplasms, Animal - genetics | Mammary Neoplasms, Animal - immunology | Antibodies, Monoclonal - pharmacology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Mice, Transgenic | Antineoplastic Combined Chemotherapy Protocols - immunology | Mice, SCID | Animals | Apoptosis Regulatory Proteins | Interferon-gamma - immunology | Receptors, Interleukin-1 Type I - genetics | Cell Line, Tumor | Interferon Type I - genetics | Programmed Cell Death 1 Receptor | Antigens, Surface | Mammary Neoplasms, Animal - drug therapy | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Trastuzumab | Biological Sciences
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2012, Volume 130, Issue 7, pp. 1577 - 1589
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2018, Volume 118, Issue 3, pp. 312 - 324
Journal Article
Clinical Immunology, ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Abstract We designed a phase I trial to investigate the safety, immune responses and clinical benefits of a five-peptide cancer vaccine in combination with... 
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | INTERLEUKIN-2 | IMMUNE-RESPONSE | LUNG | TESTIS ANTIGENS | IMMUNOLOGY | EPITOPE-PEPTIDES | IDENTIFICATION | BREAST-CANCER | IMMUNOTHERAPY | COLORECTAL-CANCER | REGULATORY T-CELLS | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors
Journal Article